Generic Formulations and API products are listed below.
CONTACT
Group Companies
GENERICS
GENERIC FORMULATIONS
| Sl. No | Molecule Name | Status |
| 1 | Atorvastatin | Commercial (USA) |
| 2 | Dapagliflozin | Tentative approval |
| 3 | Daptomycin | Commercial (USA) |
| 4 | Dasatinib | Commercial (USA) |
| 5 | Everolimus (gAfinitor) | Commercial (USA & Europe) |
| 6 | Everolimus (gZortress) | Approved |
| 7 | Fingolimod | Commercial (USA) |
| 8 | Lenalidomide | Commercial (USA) |
| 9 | Liothyronine | Commercial (USA) |
| 10 | Liraglutide (gSaxenda) | Commercial (UK) |
| 11 | Liraglutide (gVictoza) | Commercial (UK & Netherlands) |
| 12 | Micafungin | Commercial (USA) |
| 13 | Mycophenolic Acid | Commercial (USA) |
| 14 | Nitrofurantoin | Commercial (USA) |
| 15 | Norepinephrine bitartrate | Approved |
| 16 | Oxcarbazepine | Commercial (USA) |
| 17 | Oxcarbazepine | Approved |
| 18 | Pemetrexed | Tentative approval |
| 19 | Pemetrexed | Approved |
| 20 | Posaconazole | Commercial (USA & Europe) |
| 21 | Pravastatin | Commercial (USA) |
| 22 | Rivaroxaban | Approved |
| 23 | Rosuvastatin | Commercial (USA & Europe) |
| 24 | Sacubitril + Valsartan | Commercial (USA) |
| 25 | Simvastatin | Commercial (USA) |
| 26 | Tacrolimus | Commercial (USA) |
| 27 | Teriflunomide | Approved |
API
| Cardiology | |
| Sl. No | Molecule Name |
| 1 | Atorvastatin |
| 2 | Fluvastatin Sodium |
| 3 | Ivabradine |
| 4 | Pravastatin Sodium |
| 5 | Rosuvastatin |
| 6 | Sacubitril Sodium |
| 7 | Simvastatin |
| 8 | Valsaratan-Disodium |
| Anti-Diabetics | |
| Sl. No | Molecule Name |
| 1 | Dapagliflozin Butanediol |
| 2 | Dapagliflozin Propanediol |
| 3 | Empagliflozin |
| 4 | Linagliptin |
| 5 | Liraglutide |
| 6 | Repaglinide |
| 7 | Semaglutide |
| 8 | Sitagliptin |
| 9 | Vildagliptin |
| Immunosuppressants | |
| Sl. No | Molecule Name |
| 1 | Everolimus |
| 2 | Mycophenolate Mofetil |
| 3 | Mycophenolate Sodium |
| 4 | Pimecrolimus |
| 5 | Sirolimus |
| 6 | Tacrolimus |
| Multiple Sclerosis | |
| Sl. No | Molecule Name |
| 1 | Fingolimod |
| 2 | Glatiramer Acetate |
| 3 | Teriflunomide |
| Oncology | |
| Sl. No | Molecule Name |
| 1 | Cabozantinib |
| 2 | Dasatinib |
| 3 | Enzalutamide |
| 4 | Lenalidomide |
| 5 | Nintedanib Esylate |
| 6 | Olaparib |
| Blood & Blood Forming Organs | |
| Sl. No | Molecule Name |
| 1 | Apixaban |
| 2 | Dabigatran |
| 3 | Rivaroxaban |
| 4 | Ticagrelor |
| Other Key Products | |
| Sl. No | Molecule Name |
| 1 | Brinzolamide |
| 2 | Deferasirox |
| 3 | Ivacaftor |
| 4 | Lurasidon |
| 5 | Micafungin |
| 6 | Mirabegron |
| 7 | Orlistat |
| 8 | Posaconazole |
Know more
about us
KEY MANAGEMENT TEAM
PRESS RELEASES
OUR LEGACY
CORPORATE GOVERNANCE
